Business Description
Vivozon Pharmaceutical Co Ltd
ISIN : KR7082800004
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | 10.62 | |||||
Interest Coverage | 1.82 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -0.52 | |||||
Beneish M-Score | -2.24 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.7 | |||||
3-Year EPS without NRI Growth Rate | 74 | |||||
3-Year Book Growth Rate | -16.8 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.13 | |||||
9-Day RSI | 47.61 | |||||
14-Day RSI | 49.6 | |||||
6-1 Month Momentum % | 10.16 | |||||
12-1 Month Momentum % | -4.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.63 | |||||
Quick Ratio | 0.39 | |||||
Cash Ratio | 0.17 | |||||
Days Inventory | 119.52 | |||||
Days Sales Outstanding | 50.61 | |||||
Days Payable | 84.82 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.8 | |||||
Shareholder Yield % | 11.6 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 44.95 | |||||
Operating Margin % | 6.49 | |||||
Net Margin % | -3.01 | |||||
FCF Margin % | -7.11 | |||||
ROE % | -2.2 | |||||
ROA % | -1.32 | |||||
ROIC % | 2.7 | |||||
ROC (Joel Greenblatt) % | 1.88 | |||||
ROCE % | 0.57 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.93 | |||||
PB Ratio | 1.44 | |||||
Price-to-Tangible-Book | 1.61 | |||||
Price-to-Operating-Cash-Flow | 45.43 | |||||
EV-to-EBIT | 283.43 | |||||
EV-to-EBITDA | 48.07 | |||||
EV-to-Revenue | 2.28 | |||||
EV-to-FCF | -32.09 | |||||
Price-to-Median-PS-Value | 1.5 | |||||
Earnings Yield (Greenblatt) % | 0.35 | |||||
FCF Yield % | -3.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Vivozon Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 77,737.115 | ||
EPS (TTM) (â‚©) | -51 | ||
Beta | 0.63 | ||
Volatility % | 30.27 | ||
14-Day RSI | 49.6 | ||
14-Day ATR (â‚©) | 165.286915 | ||
20-Day SMA (â‚©) | 3163.5 | ||
12-1 Month Momentum % | -4.68 | ||
52-Week Range (â‚©) | 2395 - 4045 | ||
Shares Outstanding (Mil) | 47.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Vivozon Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Vivozon Pharmaceutical Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Vivozon Pharmaceutical Co Ltd Frequently Asked Questions
What is Vivozon Pharmaceutical Co Ltd(XKRX:082800)'s stock price today?
When is next earnings date of Vivozon Pharmaceutical Co Ltd(XKRX:082800)?
Does Vivozon Pharmaceutical Co Ltd(XKRX:082800) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |